Department of Neurosurgery, PD Hinduja Hospital, Mumbai, Maharashtra, India.
Neurol India. 2019 Jan-Feb;67(Supplement):S82-S91. doi: 10.4103/0028-3886.250703.
A retrospective analysis of surgically treated 354 cases of injection-related iatrogenic peripheral nerve injuries was performed. The purpose of this clinical study was to present our experience in the management of various types of injection-related peripheral nerve injuries and discuss various issues that are associated with this subset of peripheral nerve injuries.
Over a 17-year period, 354 cases of injection-related iatrogenic peripheral nerve injuries were managed surgically at the Department of Neurosurgery at P.D. Hinduja Hospital and Seth G S Medical College, Mumbai. In our series, the injection-related iatrogenic nerve injuries were following intramuscular injections, brachial nerves block procedures, subclavian and jugular venous cannulation procedures for central line placements, and routine intravenous injections in the peripheral veins of the limbs. The age of the patients ranged from 5 years to 65 years. Pain, paresthesia, and sensory-motor deficits were the common presenting features in our series. The operative procedures performed in our series were external neurolysis and excision of neuroma/contused portion of the nerve and sural nerve cable grafting. The follow-up ranged from 6 months to 84 months. There were no major intraoperative complications in our series.
In our series, functional improvement (power grade 3 or above) was noted in 190 (53.7%) patients following surgical intervention. In 164 (46.3%) patients, there was either a non-functional status or no recovery. Neurological deterioration in the form of motor weakness was noted in 9 (2.5%) patients in our series after the surgery. The best results (90.1%) were noted with radial nerve repair following surgical intervention.
Injection-related iatrogenic nerve injuries are not an uncommon problem. Surgery should be the preferred treatment option when the injured nerve fails to recover following the insult. The results are rewarding in a significant percentage of patients following timely intervention. The problem of litigation attached with this type of injury is also highlighted.
对 354 例与注射相关的医源性周围神经损伤的手术治疗进行回顾性分析。本临床研究的目的是介绍我们在各种类型的与注射相关的周围神经损伤的治疗经验,并讨论与这组周围神经损伤相关的各种问题。
在 17 年期间,354 例与注射相关的医源性周围神经损伤在孟买的 P.D. Hinduja 医院和 Seth G S 医学院神经外科接受了手术治疗。在我们的系列中,与注射相关的医源性神经损伤是在肌内注射、臂丛神经阻滞程序、锁骨下和颈内静脉置管进行中央线放置以及四肢周围静脉常规静脉注射之后发生的。患者的年龄从 5 岁到 65 岁不等。疼痛、感觉异常和感觉运动功能障碍是我们系列中的常见表现。我们的系列中进行的手术程序包括外部神经松解术和切除神经的神经瘤/挫伤部分以及腓肠神经电缆移植术。随访时间从 6 个月到 84 个月不等。我们的系列中没有出现重大的术中并发症。
在我们的系列中,190 例(53.7%)患者在手术后出现功能改善(肌力 3 级或以上)。在 164 例(46.3%)患者中,要么处于无功能状态,要么没有恢复。在手术后,我们的系列中有 9 例(2.5%)患者出现运动无力的神经恶化。在接受手术干预后,桡神经修复的效果最佳(90.1%)。
与注射相关的医源性神经损伤并不是一个罕见的问题。当受伤的神经在受到损伤后无法恢复时,手术应该是首选的治疗方法。在及时干预的情况下,患者的恢复情况是令人满意的。还强调了与这种类型的损伤相关的诉讼问题。